Cato Institute
AquaBounty saga: The troubling story of why it took 25 years and $100 million to bring a fast-growing, sustainable genetically-engineered fish to market
The first U.S. sales of the AquAdvantage salmon, a faster‐ growing, genetically engineered fish, have finally begun. The farmed fish ...
Are coronavirus fears breathing new life into old childhood diseases?
Fear among vulnerable patients that they may contract and succumb to a COVID-19 infection is completely understandable. It is less ...
